Skip to main content
. 2021 Feb 3;13(2):211. doi: 10.3390/pharmaceutics13020211

Figure 4.

Figure 4

In vitro dissolution results of the active pharmaceutical ingredient (API) (rawMX), the physical mixtures (pmMX1_LEU0, pmMX1_LEU0.5, and pmMX1_LEU1), and the prepared samples (nanoMX1_LEU0, nanoMX1_LEU0.5, and nanoMX1_LEU1). Data are means ± SD (n = 3 independent measurements).